Nonpulmonary Treatments for Pediatric Acute Respiratory Distress Syndrome: From the Second Pediatric Acute Lung

Stacey L Valentine1, Sapna R Kudchadkar2, Shan Ward3

  • 1Department of Pediatrics, Division of Pediatric Critical Care, University of Massachusetts Children´s Medical Center, Worcester, MA.

Insights

This review updates nonpulmonary treatments for pediatric acute respiratory distress syndrome (PARDS). It provides clinical recommendations and good practice statements to optimize care and guide future research in PARDS management.

Area of Science:

  • Pediatric Critical Care Medicine
  • Respiratory Medicine
  • Pulmonology

Background:

  • Pediatric Acute Respiratory Distress Syndrome (PARDS) requires comprehensive management strategies.
  • Nonpulmonary adjunctive therapies play a crucial role in optimizing outcomes for children with PARDS.
  • The Second Pediatric Acute Lung Injury Consensus Conference aimed to update the evidence base for these treatments.

Approach:

  • Systematic literature review across major medical databases (MEDLINE, Embase, CINAHL).
  • Inclusion of studies focusing on nonpulmonary therapies for PARDS or hypoxic respiratory failure.
  • Application of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework for evidence synthesis.

Key Points:

  • Five clinical practice recommendations were developed for neuromuscular blockade, nutrition, fluid management, and transfusion.
  • Thirteen good practice statements address sedation, delirium, sleep, and rehabilitation in PARDS.
  • Three research statements highlight areas for future investigation in nonpulmonary PARDS therapies.

Conclusions:

  • The generated recommendations and statements aim to standardize and improve care for pediatric patients with PARDS.
  • This evidence-based guidance addresses critical nonpulmonary aspects of PARDS management.
  • Identifying research gaps will drive advancements in treating pediatric respiratory failure.
Abstract

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
180
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
413
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.7K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.3K
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
189
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
258